Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease

Ben Li(St. Michael's Hospital), Mohammad Qadura(St. Michael's Hospital), Shubha Jain(St. Michael's Hospital), Muzammil H. Syed(St. Michael's Hospital), Abdelrahman Zamzam(St. Michael's Hospital), Rawand Abdin(McMaster University), Niousha Jahanpour(St. Michael's Hospital)

Biomolecules

June 21, 2022

10.3390/biom12070860

Cited by 17

Related Papers

Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies

|Stem Cells|2017|205

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response

|Blood|2008|82

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

|Blood|2009|63

Serum Metabolic Signatures of Chronic Limb-Threatening Ischemia in Patients with Peripheral Artery Disease

|Journal of Clinical Medicine|2020|62

Endothelial-specific Loss of IFT88 Promotes Endothelial-to-Mesenchymal Transition and Exacerbates Bleomycin-induced Pulmonary Fibrosis

|Scientific Reports|2020|57